Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

623
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
623
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

513
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
513
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

400
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
400
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

6.1K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
6.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

102
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
102

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survey of Vaccine Hesitancy in Patients Visiting Three Tertiary-care Emergency Departments in Southeast Louisiana.

The western journal of emergency medicine·2024
Same author

Sarcoidosis.

Immunology and allergy clinics of North America·2023
Same author

Anaphylaxis, Angioedema, and Other Immunologic Emergencies.

Immunology and allergy clinics of North America·2023
Same author

Allergic and Immunologic Emergencies.

Emergency medicine clinics of North America·2021
Same author

Evidence-Based Clinical Criteria for Computed Tomography Imaging in Odontogenic Infections.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons·2018
Same author

Air and its Sonographic Appearance: Understanding the Artifacts.

The Journal of emergency medicine·2017

Related Experiment Video

Updated: Oct 13, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.3K

Sarcoidosis.

Denrick Cooper1, Salvador Suau2

  • 1Department of Emergency Medicine, Ochsner Health System, 1514 Jefferson Hwy, New Orleans, LA 71021, USA.

Emergency Medicine Clinics of North America
|November 16, 2021
PubMed
Summary

Sarcoidosis presents widely, with acute cases requiring prompt diagnosis and treatment to prevent severe outcomes. While milder forms respond to steroids, severe sarcoidosis necessitates specialized care.

Keywords:
GranulomatousNongranulomatousSarcoidosis

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.8K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.1K

Related Experiment Videos

Last Updated: Oct 13, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.3K
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.8K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.1K

Area of Science:

  • Systemic Inflammatory Diseases
  • Pulmonary Medicine
  • Neurology
  • Cardiology
  • Ophthalmology

Background:

  • Sarcoidosis is a multisystem inflammatory disease with diverse clinical manifestations.
  • Pulmonary involvement is most frequent, but cardiac, optic, and neurologic sarcoidosis significantly increase morbidity and mortality.
  • Acute presentations, particularly in emergency settings, pose diagnostic challenges and can lead to severe patient outcomes.

Purpose of the Study:

  • To review the acute presentations of sarcoidosis.
  • To highlight the importance of early diagnosis and management in emergency settings.
  • To discuss prognosis and treatment strategies for different sarcoidosis severities.

Main Methods:

  • Literature review focusing on acute sarcoidosis presentations.
  • Analysis of case reports and clinical studies concerning emergency room encounters.
  • Synthesis of current knowledge on diagnosis, treatment, and prognosis.

Main Results:

  • Acute sarcoidosis can manifest with life-altering effects if not promptly identified.
  • Less severe sarcoidosis cases generally have a favorable prognosis with steroid therapy.
  • Resistant and severe sarcoidosis forms are associated with high mortality and morbidity.

Conclusions:

  • Early recognition and appropriate management of acute sarcoidosis are crucial, especially in emergency departments.
  • Tailored treatment, including steroid therapy for milder cases and specialized follow-up for severe or resistant disease, is essential.
  • Understanding the varied manifestations of sarcoidosis is key to improving patient outcomes.